Sumatriptan, a serotonin 5HT1B receptor agonist, acutely reduces insulin secretion and sensitivity and glucose effectiveness in overweight humans: A double-blinded placebo-controlled cross-over trial.
Diabetes Obes Metab
; 25(10): 3059-3063, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37312648
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Insulin Resistance
/
Glucose
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Animals
/
Humans
Language:
En
Journal:
Diabetes Obes Metab
Journal subject:
ENDOCRINOLOGIA
/
METABOLISMO
Year:
2023
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom